Clincosm LogoSign in Get a demo

chronic hepatitis c infection

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Against HCV Based on Direct-acting Antivirals in Real-life

Completed
  • Chronic Hepatitis C Infection
  • Seville, Andalusia, Spain
    Valme University Hospital
Jun 22, 2022

Chronic Hepatitis C Infection Trial in Worldwide (Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • San Francisco, California
  • +20 more
Sep 7, 2021

Chronic Hepatitis C Infection Trial in Richmond (HCVax)

Recruiting
  • Chronic Hepatitis C Infection
  • HCVax
  • Richmond, Virginia
    Virginia Commonwealth University, Medical Center
Sep 28, 2021

Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

Completed
  • Chronic Hepatitis C Infection
  • +2 more
  • Hong Kong, Hong Kong, China
    Humanity and Health GI and Liver Centre
Aug 27, 2021

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

Recruiting
  • Chronic Hepatitis C Infection
    • Beijing, Beijing, China
    • +2 more
    Aug 27, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +4 more
    • (no location specified)
    Jul 29, 2021

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +4 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • ABT-450/r/ABT-267, ABT-333
    • Ribavirin (RBV)
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial in United States (Fuzheng Huayu, Placebo)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Fuzheng Huayu
    • Placebo
    • Coronado, California
    • +7 more
    Apr 28, 2021

    Chronic Hepatitis C Infection Trial in Taiwan (JNJ-47910382 30 mg, JNJ-47910382 90 mg, JNJ-47910382 200 mg)

    Terminated
    • Chronic Hepatitis C Infection
    • JNJ-47910382 30 mg
    • +3 more
    • Kaohsiung, Taiwan
    • +4 more
    Mar 25, 2019

    Chronic Hepatitis C Infection Trial in United States (ABT-267, ABT-450, ABT-333)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Bakersfield, California
    • +3 more
    Jun 1, 2018

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, Placebo)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • (no location specified)
    May 2, 2018

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Pegylated Interferon a-2a (PegINF))

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +3 more
    • (no location specified)
    May 2, 2018

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Telaprevir)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +3 more
    • (no location specified)
    May 2, 2018

    Chronic Hepatitis C Infection Trial (ABT-450/ritonavir, ABT-267)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/ritonavir, ABT-267
    • (no location specified)
    Apr 30, 2018

    Chronic Hepatitis C Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Chronic Hepatitis C
    • (no location specified)
    Apr 30, 2018

    Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (SOF+RBV, SOF+DCV, LDV/SOF)

    Completed
    • Chronic Hepatitis C Infection
    • Beijing, Beijing, China
    • +1 more
    Mar 16, 2018

    Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (sofosbuvir and daclatasvir, ledipasvir/sofosbuvir)

    Completed
    • Chronic Hepatitis C Infection
    • Beijing, Beijing, China
    • +1 more
    Mar 16, 2018

    Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (Sofosbuvir, Daclatasvir)

    Completed
    • Chronic Hepatitis C Infection
    • Beijing, Beijing, China
    • +1 more
    Mar 16, 2018

    Chronic Hepatitis C Infection Trial (ombitasvir/paritaprevir/ritonavir and dasabuvir, Sofosbuvir, Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ombitasvir/paritaprevir/ritonavir and dasabuvir
    • +2 more
    • (no location specified)
    Nov 22, 2017